Medifast provided earnings guidance for the first quarter of 2024. For the period, the company expects revenue to be in the range of $155 million to $175 million and diluted EPS to be in the range of $0.25 to $0.95.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.8 USD | +8.63% | +1.68% | -63.11% |
Apr. 30 | Medifast Shares Drop as Q1 Adjusted Earnings, Revenue Decline; Sets Q2 Guidance | MT |
Apr. 30 | Wall Street Poised for Cautious Day Ahead of Key Numbers, Earnings, Fed Report | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-63.11% | 265M | |
+13.74% | 8.18B | |
+5.29% | 7.53B | |
-0.42% | 5.89B | |
-6.67% | 3.7B | |
-10.75% | 3.57B | |
-8.21% | 1.26B | |
-29.10% | 1.08B | |
+14.92% | 991M | |
-12.46% | 894M |
- Stock Market
- Equities
- MED Stock
- News Medifast, Inc.
- Medifast Provides Earnings Guidance for the First Quarter of 2024